← ImmunityBio, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $44k |
$45k
+2.27%
|
$47k
+4.44%
|
$43k
-8.51%
|
$111k
+158.14%
|
$934k
+741.44%
|
$240k
-74.30%
|
$622k
+159.17%
|
$14.7m
+2270.58%
|
$113.3m
+668.31%
|
$165.8m
+46.35%
|
|
| Cost of Revenue | $29.2m |
$42.0m
+44.22%
|
$55.7m
+32.52%
|
$49.8m
-10.65%
|
$64.5m
+29.52%
|
$196.0m
+203.89%
|
$0
-100.00%
|
$0 | $0 | $753k |
$1.1m
+45.42%
|
|
| Gross Profit (Calculated) (derived) | ($29.1m) |
($42.0m)
-44.28%
|
($55.7m)
-32.55%
|
($49.7m)
+10.65%
|
($64.4m)
-29.41%
|
($195.0m)
-202.96%
|
$240k
+100.12%
|
$622k
+159.17%
|
$14.7m
+2270.58%
|
$112.5m
+663.21%
|
— | |
| Research and Development Expense | $29.2m | $42.0m | $55.7m | $49.8m | $64.5m | $196.0m | $248.1m | $232.4m | $190.1m | — | $243.9m | |
| Selling, General and Administrative Expense | $95.4m | $57.1m | $42.7m | $18.1m | $27.3m | $135.3m | $102.7m | $129.6m | $168.8m | $150.0m | $172.6m | |
| Amortization of Intangible Assets | $2.6m | $2.3m | $2.3m | $600k | — | — | — | $2.0m | $2.0m | — | — | |
| Operating Expenses | $124.5m | $99.2m | $98.4m | $67.8m | $91.7m | $331.2m | $351.5m | $362.9m | $358.9m | — | $417.6m | |
| Operating Income (Loss) | ($124.5m) |
($99.1m)
+20.39%
|
($98.4m)
+0.74%
|
($67.8m)
+31.08%
|
($91.6m)
-35.13%
|
($330.3m)
-260.47%
|
($351.3m)
-6.36%
|
($362.2m)
-3.12%
|
($344.2m)
+4.99%
|
($256.0m)
+25.61%
|
($251.8m)
+1.65%
|
|
| Interest Expense | $66k | $618k | $433k | $19k | $41k | $14.8m | $63.5m | $129.2m | $114.7m | $60.9m | $114.5m | |
| Investment Income, Net | $3.1m | $2.7m | $1.9m | $1.6m | $366k | — | — | — | — | — | — | |
| Debt and Equity Securities, Unrealized Gain (Loss) | — | — | — | — | — | ($4.6m) | ($4.2m) | ($1.6m) | ($632k) | $0 | — | |
| Fair Value, Option, Changes in Fair Value, Gain (Loss) | — | — | — | — | — | — | — | ($36.2m) | $43.5m | ($42.8m) | — | |
| Gain (Loss) on Investments | — | — | — | — | — | ($4.1m) | ($3.1m) | $1.1m | $8.0m | $6.4m | — | |
| Other Nonoperating Income (Expense) | $88k | $157k | $236k | $298k | ($1.1m) | $193k | ($736k) | ($2.2m) | ($15k) | ($2.2m) | — | |
| Income (Loss) from Equity Method Investments | $0 | $0 | — | $0 | $0 | ($803k) | ($12.1m) | ($7.5m) | $0 | $0 | — | |
| Interest and Other Income | — | — | — | — | — | $836k | $2.7m | $863k | $2.4m | $2.7m | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | ($118.7m) | ($94.7m) | ($94.4m) | ($65.3m) | ($92.4m) | ($347.2m) | ($413.7m) | ($581.1m) | ($410.5m) | ($348.4m) | ($992.6m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | ($121.4m) | ($96.9m) | ($96.7m) | ($65.9m) | ($92.4m) | ($349.8m) | ($417.3m) | ($583.9m) | ($413.6m) | ($351.6m) | ($992.6m) | |
| Current Income Tax Expense (Benefit) | $3k | $4k | $3k | $3k | $5k | $9k | $38k | ($26k) | $0 | $4k | ($161k) | |
| Income Tax Expense (Benefit) | ($572k) | ($493k) | ($503k) | ($97k) | $5k | $9k | $34k | ($40k) | $0 | ($135k) | ($161k) | |
| Net Income (Loss) Attributable to Parent | ($120.8m) |
($96.4m)
+20.19%
|
($96.2m)
+0.20%
|
($65.8m)
+31.63%
|
($92.4m)
-40.42%
|
($346.8m)
-275.38%
|
($416.6m)
-20.12%
|
($583.2m)
-40.00%
|
($413.6m)
+29.09%
|
($351.4m)
+15.03%
|
($992.4m)
-182.40%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | $121.4m | $96.9m | $96.7m | $65.9m | $92.4m | ($3.1m) | ($753k) | ($656k) | ($81k) | ($74k) | ($992.4m) | |
| Earnings Per Share, Basic | — | — | — | — | — | ($0.89) | ($1.04) | ($1.15) | ($0.59) | ($0.38) | ($0.95) | |
| Earnings Per Share, Diluted | ($1.47) | ($1.20) | ($1.22) | ($0.70) | ($0.89) | ($0.89) | ($1.04) | ($1.15) | ($0.62) | ($0.38) | ($0.95) | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | — | 389.2m | 399.9m | 508.6m | 697.3m | 919.9m | 1.0b | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | — | 389.2m | 399.9m | 508.6m | 700.4m | 919.9m | 1.0b | |
| Additional Financial Items | ||||||||||||
| Costs and Expenses | — | — | — | — | — | — | — | — | — | $369.3m | — | |
| Realized Investment Gains (Losses) | $111k | $37k | $3k | ($4k) | ($9k) | $167k | ($122k) | $15k | ($42k) | ($292k) | — |